Ethyl 1-[(2-Chlorobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate

ID: ALA4757679

PubChem CID: 162657228

Max Phase: Preclinical

Molecular Formula: C21H18ClN3O3

Molecular Weight: 395.85

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1c(C)nc(-c2cccc(C#N)c2)n1OCc1ccccc1Cl

Standard InChI:  InChI=1S/C21H18ClN3O3/c1-3-27-21(26)19-14(2)24-20(16-9-6-7-15(11-16)12-23)25(19)28-13-17-8-4-5-10-18(17)22/h4-11H,3,13H2,1-2H3

Standard InChI Key:  XWKCRQLKTQGBES-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   13.1768  -13.2525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1757  -14.0720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8837  -14.4810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5934  -14.0716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5906  -13.2489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8819  -12.8436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2945  -12.8393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0423  -13.1688    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5868  -12.5595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1755  -11.8533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3769  -12.0263    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3998  -12.6418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5050  -11.1055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3174  -11.0169    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0221  -10.4462    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6469  -10.2691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4593  -10.1805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8865  -15.2942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8863  -16.1114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7675  -11.4818    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9913  -11.7373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3819  -11.1928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5522  -10.3965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9437   -9.8523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1665  -10.1076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0013  -10.9123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6112  -11.4530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3292  -10.1432    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  1  0
  5  7  1  0
  9 12  1  0
 10 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 18 19  3  0
  3 18  1  0
 11 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 23 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4757679

    ---

Associated Targets(non-human)

Plasma (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.85Molecular Weight (Monoisotopic): 395.1037AlogP: 4.19#Rotatable Bonds: 6
Polar Surface Area: 77.14Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.21CX LogP: 4.18CX LogD: 4.18
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.67

References

1. Lei Y,Zhang B,Liu D,Zhao J,Dai X,Gao J,Mao Q,Feng Y,Zhao J,Lin F,Duan Y,Zhang Y,Bao Z,Yang Y,Mou Y,Wang S.  (2020)  Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y and P2Y as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor.,  63  (24): [PMID:33307675] [10.1021/acs.jmedchem.0c01524]

Source